HARVARD BIOSCIENCE INC (HBIO)
About HARVARD BIOSCIENCE INC
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $86.5M
- Net income
- -$56.7M
- Total assets
- $80.1M
- Market cap
- $27.1M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $27.1M
- Shares outstanding
- 3.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 7, 2000
Harvard Bioscience Inc (HBIO) Stock Price
- Reported a net loss of $56.7M in FY2025.
- Trading 4% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review HARVARD BIOSCIENCE INC.
Write a review
News about HARVARD BIOSCIENCE INC
News & sentiment via Polygon.io
Harvard Bioscience Inc: frequently asked questions
Is Harvard Bioscience Inc an American company?
Harvard Bioscience Inc is a US-based company headquartered in Holliston, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Harvard Bioscience Inc headquartered?
Harvard Bioscience Inc is headquartered in Holliston, Massachusetts, United States.
Is Harvard Bioscience Inc publicly traded?
Yes — Harvard Bioscience Inc is a publicly traded company. Its stock trades under the ticker symbol HBIO on the NASDAQ.
What does Harvard Bioscience Inc do?
Harvard Bioscience Inc is an American Medical Devices company in the Health & Beauty sector.
